Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Thallous chloride, tl 201

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Thallous chloride, tl 201 used for?
The FDA-approved label (THALLOUS CHLORIDE Tl 201, Curium US LLC, December 22, 2025) says: “Thallous Chloride Tl 201 Injection is indicated for use with planar scintigraphy or single-photon emission computed tomography (SPECT) for the following applications: Myocardial perfusion imaging in adults for the diagnosis of coronary artery disease by localization of …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Thallous chloride, tl 201 have a boxed warning?
No. None of the 1 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Thallous chloride, tl 201?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Thallous chloride, tl 201 been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Thallous chloride, tl 201?
1 company lists prescription products of Thallous chloride, tl 201 in the FDA NDC Directory, including Curium US LLC.

What Thallous chloride, tl 201 is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

Thallous Chloride Tl 201 Injection is indicated for use with planar scintigraphy or single-photon emission computed tomography (SPECT) for the following applications: Myocardial perfusion imaging in adults for the diagnosis of coronary artery disease by localization of …

— FDA label: THALLOUS CHLORIDE Tl 201, Curium US LLC, effective December 22, 2025. Read the full label on DailyMed →

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Conditions named on the label

These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.

Related medical specialties

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

Forms and how it is given

Dosage formsInjection, solution
RouteIntravenous
Prescription products1 in the FDA NDC Directory

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA018150
THALLOUS CHLORIDE TL 201
CuriumOctober 23, 1979 17, latest December 10, 2025
2025: Labeling · 2016: Labeling · 2012: Labeling

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

SPL set ID of the quoted label0da81fc0-a137-46d3-9378-d8053a82e61a
FDA labels (SPL)1
FDA applicationsNDA018150
Active ingredients (FDA)THALLOUS CHLORIDE TL-201

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — THALLOUS CHLORIDE Tl 201, Curium US LLC, effective December 22, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers